5 results match your criteria: "Clarunis - University Digestive Health Care Center Basel[Affiliation]"
Ann Surg
November 2024
Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Germany.
Objective: To investigate patency and clinical outcomes of alloplastic and other venous interposition graft materials in pancreatic surgery.
Background: Vascular pancreatic surgery is increasingly performed for locally advanced pancreatic neoplasms. Different than other centers, we prefer to use alloplastic vascular graft materials for superior mesenteric vein and portal vein interposition in pancreatic surgery.
Ann Surg
September 2024
Department of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Objective: To assess the prognostic impact of margin status in patients with resected intraductal papillary mucinous neoplasms (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) and to inform future intraoperative decision-making on handling differing degrees of dysplasia on frozen section.
Summary Background Data: The ideal oncologic surgical outcome is a negative transection margin with normal pancreatic epithelium left behind. However, the prognostic significance of reresecting certain degrees of dysplasia or invasive cancer at the pancreatic neck margin during pancreatectomy for IPMN-derived PDAC is debatable.
Langenbecks Arch Surg
June 2024
Department of Visceral Surgery, Clarunis University Digestive Health Care Center Basel, Spitalstrasse 21, Basel, 4031, Switzerland.
Purpose: The purpose of this study was to assess the effect of training with a personal, portable laparoscopic endo-trainer (PLET) on residents' laparoscopic skills.
Methods: The study took place at a tertiary-care academic university hospital in Switzerland. All participants were randomized to either a home- or hospital-based PLET training group, and surgical skill performance was assessed using five laparoscopic exercises.
BMJ Case Rep
April 2024
Department of Visceral Surgery, Clarunis University Digestive Health Care Center Basel, Basel, Switzerland.
In this report, two cases of patients with severe adverse events after an adjuvant treatment with capecitabine are described in detail. The first patient suffered from a severe ileocolitis, where ultimately intensive care treatment, total colectomy and ileum resection was necessary. The second patient experienced a toxic enteritis, which could be managed conservatively.
View Article and Find Full Text PDFLangenbecks Arch Surg
April 2024
Department of Visceral Surgery, Clarunis - University Digestive Health Care Center Basel, Postfach 4002, Basel, Switzerland.